Quick Answer
Cytosorbents Corp reported Total Revenue of $22.50 million for fiscal year 2018.
Cytosorbents Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2018 | $22.50M | +48.5% |
| 2017 | $15.15M | +59.0% |
| 2016 | $9.53M | +98.8% |
| 2015 | $4.79M | +16.2% |
| 2014 | $4.12M | +70.2% |
| 2013 | $2.42M | +80.4% |
| 2012 | $1.34M | +3622.3% |
| 2011 | $36.1K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2019 | $6.23M | +8.3% | +20.0% |
| March 31, 2019 | $5.19M | +5.4% | -9.6% |
| September 30, 2018 | $5.74M | +50.2% | -0.2% |
| June 30, 2018 | $5.76M | +61.4% | +16.9% |
| March 31, 2018 | $4.92M | +58.2% | +28.8% |
| September 30, 2017 | $3.82M | +58.6% | +7.2% |
| June 30, 2017 | $3.57M | +60.5% | +14.5% |
| March 31, 2017 | $3.11M | +72.0% | +29.1% |
- Cytosorbents Corp showed an increase of +48.5% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2018 period, Cytosorbents Corp’s total revenue has grown by 62275.7% (from $36.1 thousand to $22.50 million).
- The most recent figure is from Cytosorbents Corp’s fiscal year 2018 report (Form 10-K), filed with the SEC on March 7, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: